As scientists seek to understand the molecular basis of energy production, aging, and disease, one area remains especially elusive: cellular redox metabolites. Finnish biotech company NADMED is ...

Registration details for the webinar are as follows: The presentation slides and a link to the live and archived webcast will also be available on the Events & News – Events page of Jasper's Investor ...

Specifically, the team is hoping to create seaweed-based housings to replace traditional petroleum plastics without changing the way such diagnostic lateral flow tests work. To accomplish this, the ...

The global phycoerythrin market is anticipated to grow from USD 5.18 million in 2025 to approximately USD 11.30 million by ...

Glownetics, a biotechnology-driven skincare brand, has officially launched its advanced At Home Vampire Facial system—bringing one of the beauty industry’s most coveted treatments directly to ...

Opportunities in the Molecular Biology Enzymes Reagents and Kits market include rising R&D investments and growing demand for ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

The global phycoerythrin market is on track to nearly double in value over the next decade, increasing from USD 5.18 million ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

When companies do solve that puzzle, the rewards can be huge: As Modern CEO went to press, Exact Sciences announced it was selling to Abbott in a deal valued at $21 billion.